TY - JOUR
T1 - Global guideline for the diagnosis and management of cryptococcosis
T2 - an initiative of the ECMM and ISHAM in cooperation with the ASM
AU - Chang, Christina C
AU - Harrison, Thomas S
AU - Bicanic, Tihana A
AU - Chayakulkeeree, Methee
AU - Sorrell, Tania C
AU - Warris, Adilia
AU - Hagen, Ferry
AU - Spec, Andrej
AU - Oladele, Rita
AU - Govender, Nelesh P
AU - Chen, Sharon C
AU - Mody, Christopher H
AU - Groll, Andreas H
AU - Chen, Yee-Chun
AU - Lionakis, Michail S
AU - Alanio, Alexandre
AU - Castañeda, Elizabeth
AU - Lizarazo, Jairo
AU - Vidal, José E
AU - Takazono, Takahiro
AU - Hoenigl, Martin
AU - Alffenaar, Jan-Willem
AU - Gangneux, Jean-Pierre
AU - Soman, Rajeev
AU - Zhu, Li-Ping
AU - Bonifaz, Alexandro
AU - Jarvis, Joseph N
AU - Day, Jeremy N
AU - Klimko, Nikolai
AU - Salmanton-García, Jon
AU - Jouvion, Grégory
AU - Meya, David B
AU - Lawrence, David
AU - Rahn, Sebastian
AU - Bongomin, Felix
AU - McMullan, Brendan J
AU - Sprute, Rosanne
AU - Nyazika, Tinashe K
AU - Beardsley, Justin
AU - Carlesse, Fabianne
AU - Heath, Christopher H
AU - Ayanlowo, Olusola O
AU - Mashedi, Olga M
AU - Queiroz-Telles Filho, Flavio
AU - Hosseinipour, Mina C
AU - Patel, Atul K
AU - Temfack, Elvis
AU - Singh, Nina
AU - Cornely, Oliver A
AU - Boulware, David R
AU - Lortholary, Olivier
AU - Pappas, Peter G
AU - Perfect, John R
N1 - Copyright © 2024 Elsevier Ltd. All rights reserved.
PY - 2024/8
Y1 - 2024/8
N2 - Cryptococcosis is a major worldwide disseminated invasive fungal infection. Cryptococcosis, particularly in its most lethal manifestation of cryptococcal meningitis, accounts for substantial mortality and morbidity. The breadth of the clinical cryptococcosis syndromes, the different patient types at-risk and affected, and the vastly disparate resource settings where clinicians practice pose a complex array of challenges. Expert contributors from diverse regions of the world have collated data, reviewed the evidence, and provided insightful guideline recommendations for health practitioners across the globe. This guideline offers updated practical guidance and implementable recommendations on the clinical approaches, screening, diagnosis, management, and follow-up care of a patient with cryptococcosis and serves as a comprehensive synthesis of current evidence on cryptococcosis. This Review seeks to facilitate optimal clinical decision making on cryptococcosis and addresses the myriad of clinical complications by incorporating data from historical and contemporary clinical trials. This guideline is grounded on a set of core management principles, while acknowledging the practical challenges of antifungal access and resource limitations faced by many clinicians and patients. More than 70 societies internationally have endorsed the content, structure, evidence, recommendation, and pragmatic wisdom of this global cryptococcosis guideline to inform clinicians about the past, present, and future of care for a patient with cryptococcosis.
AB - Cryptococcosis is a major worldwide disseminated invasive fungal infection. Cryptococcosis, particularly in its most lethal manifestation of cryptococcal meningitis, accounts for substantial mortality and morbidity. The breadth of the clinical cryptococcosis syndromes, the different patient types at-risk and affected, and the vastly disparate resource settings where clinicians practice pose a complex array of challenges. Expert contributors from diverse regions of the world have collated data, reviewed the evidence, and provided insightful guideline recommendations for health practitioners across the globe. This guideline offers updated practical guidance and implementable recommendations on the clinical approaches, screening, diagnosis, management, and follow-up care of a patient with cryptococcosis and serves as a comprehensive synthesis of current evidence on cryptococcosis. This Review seeks to facilitate optimal clinical decision making on cryptococcosis and addresses the myriad of clinical complications by incorporating data from historical and contemporary clinical trials. This guideline is grounded on a set of core management principles, while acknowledging the practical challenges of antifungal access and resource limitations faced by many clinicians and patients. More than 70 societies internationally have endorsed the content, structure, evidence, recommendation, and pragmatic wisdom of this global cryptococcosis guideline to inform clinicians about the past, present, and future of care for a patient with cryptococcosis.
KW - Humans
KW - Cryptococcosis/diagnosis
KW - Antifungal Agents/therapeutic use
KW - Practice Guidelines as Topic
KW - Global Health
KW - Meningitis, Cryptococcal/diagnosis
U2 - 10.1016/S1473-3099(23)00731-4
DO - 10.1016/S1473-3099(23)00731-4
M3 - Book/Film/Article review
C2 - 38346436
SN - 1473-3099
VL - 24
SP - e495-e512
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 8
ER -